BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 4, 2010
View Archived Issues
Molecular Reasons Behind Tamiflu Resistance Found
Read More
RetroVirox Building Antiviral Candidates for Others to Grow
Read More
Clinic Roundup
Read More
Stock Movers
Read More
Other News To Note
Read More
Arena Raising $35.5M in Stock Sale to Deerfield as PDUFA Date Looms
Arena Pharmaceuticals Inc. has agreed to sell shares to Deerfield Management for $35.5 million, money that will bolster the biotech's cash as it seeks FDA approval of its obesity compound lorcaserin. (BioWorld Today)
Read More
Tioga Seeking to Change D-IBS Landscape with PIII Under Way
Read More